Saturday, August 22, 2026

TOPICS

Home Tags Johnson & Johnson

Tag: Johnson & Johnson

R.I. to resume administration of J&J COVID-19 vaccine

PROVIDENCE – Rhode Island will resume the administration of the Johnson & Johnson COVID-19 vaccine, the R.I. Department of Health announced Monday evening. The move...
IN GOOD HANDS: Jennifer Beaugh, right, pharmacy supervisor at The Miriam Hospital, hands a dose of COVID-19 vaccine to Dr. Karen Tashima at a clinic at The Miriam. Tashima is overseeing a clinical trial of the COVID-19 vaccine that hasn’t yet received U.S. government approval.  / COURTESY LIFESPAN CORP.

R.I. plays role in making new COVID-19 vaccines

What seemed like an epic race for an effective COVID-19 vaccine has produced several options that have people rolling up their sleeves across Rhode...

COVID-19 vaccine subcommittee approves J&J vaccine; McKee restates priority for teachers

PROVIDENCE – The R.I. COVID-19 Vaccine Subcommittee approved the immediate use of the Johnson & Johnson one-dose vaccine Wednesday morning, days after the federal...
John Hesselmann

The future of M&A in health care

As we take stock of health care mergers and acquisitions activity in 2020 – marked by both mega consolidations and deal breakups – it...
Niamh Perreault

Companies can win big by thinking small

I’m a huge fan of Rhode Island. Growing up in a small, close-knit part of the world such as Northern Ireland drew me to...
CRISIS MANAGER: Gov. Gina M. Raimondo has had to make many difficult decisions in 2020 as Rhode Island grappled with the COVID-19 pandemic, and she says the recovery process may be difficult, too. / PBN FILE PHOTO/MICHAEL SALERNO

‘It’s going to take a while to get back on our...

Gov. Gina M. Raimondo started 2020, her sixth year as governor, by outlining her priorities to improve education, affordable housing and job opportunities for...
JOHNSON & JOHNSON is beginning a huge final study to try to prove if the single-dose vaccine can protect against the coronavirus. / COURTESY JOHNSON & JOHNSON/CHERYL GERBER

Late-stage study of first single-shot vaccine begins in U.S.

Johnson & Johnson is beginning a huge final study to try to prove if a single-dose COVID-19 vaccine can protect against the virus. The study...

Tech Collective to host webinar on data ethics

PROVIDENCE – Tech Collective will host a webinar on data ethics and its power in relation to the size of a company July 16. The...
LAB WORK: Research associates Mitchell McAlister and Olivia Morin work in the lab at EpiVax in Providence. The biotechnology company recently began working on a coronavirus vaccine. / PBN PHOTO/MICHAEL SALERNO

EpiVax devises ‘recipe’ for coronavirus vaccine

Staying current on the frantic pace of the coronavirus outbreak means following reports by major news outlets for most people, but analysts at EpiVax...
VACANT SPACE: Andrew Galvin, first vice president for commercial realtor CBRE Inc., which is marketing office space on the sixth and seventh floors of the Wexford Science & Technology building in Providence, says the underdeveloped look of the vacant space is intentional, designed to give prospective tenants the freedom to build out the space to their needs. / PBN PHOTO/MICHAEL SALERNO

At Wexford building, empty floors are no worry

It’s 11 a.m. on a sunny, January morning, and the Wexford Science & Technology building – located in Providence’s I-195 Redevelopment District – booms...
- Featured Event -

Latest News